Showing results (181-190 of 544) with videos related to
Sort By:
Pageof 55
Infection and Immunity|September 14, 2002
Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malariaBenjamin Stoelcker, Thomas Hehlgans, Karin Weigl, et al.Cytokine|September 1, 1993
Protective effect of natural TNF-binding protein on human TNF-induced toxicity in miceA Ythier, M P Gascon, P Juillard, et al.Infection and Immunity|December 22, 2005
Platelets potentiate brain endothelial alterations induced by Plasmodium falciparumSamuel C Wassmer, Valéry Combes, Francisco J Candal, et al.Thrombosis and Haemostasis|February 25, 1988
AT III Barcelona: a familial quantitative-qualitative AT III deficiencyE Grau, J Fontcuberta, J Félez, et al.Thrombosis and Haemostasis|February 19, 1990
Detection of both type 1 and type 2 plasminogen activator inhibitors in human monocytesJ C Castellote, E Grau, M A Linde, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|September 11, 2016
Smokers' Perspectives on Texting for Tobacco Dependence Treatment: A Qualitative AnalysisLauretta E Grau, Timothy Pham, Teresa O'Leary, et al.Critical Reviews in Oncology/Hematology|April 25, 2020
Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A reviewTamkin Ahmadzada, Steven Kao, Glen Reid, et al.Immunology|December 1, 1992
Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptorP F Piguet, G E Grau, C Vesin, et al.The New England Journal of Medicine|August 18, 1988
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpuraE Girardin, G E Grau, J M Dayer, et al.Nature|March 15, 1990
Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosisP F Piguet, M A Collart, G E Grau, et al.Pageof 55